Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPACITY: Methyldopa in Formerly Preeclamptic Women
NCT00117546Phase 4Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in preeclampsia comparing Methyldopa with Placebo (2 arms). Primary endpoint: normalized plasma volume at 1 month. Status: unknown.
02
Drugs
methyldopa
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT00117546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117546.